RSS

mergers

An upcoming merger agreement between Pfizer and Anacor, worth around $5.2bn, is set to boost the companies’ pipeline candidates in the atopic dermatitis space, according to GlobalData more

News

It seems we’re never far from a merger or acquisition in the pharmaceutical sector more

Opinion

BioAlliance Pharma has received pre-approval from NASDAQ OMX Copenhagen for the secondary listing and admission to trading on NASDAQ OMX Copenhagen of the shares of BioAlliance Pharma SA. more